Zymeworks Inc.
ZYME
$27.49
-$0.63-2.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 37.13M | 81.26M | 105.97M | 134.48M | 122.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 37.13M | 81.26M | 105.97M | 134.48M | 122.87M |
| Cost of Revenue | 128.71M | 135.72M | 137.00M | 142.83M | 143.60M |
| Gross Profit | -91.58M | -54.46M | -31.04M | -8.35M | -20.74M |
| SG&A Expenses | 63.98M | 59.60M | 61.51M | 62.27M | 61.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 192.69M | 195.32M | 198.51M | 205.10M | 205.58M |
| Operating Income | -155.56M | -114.05M | -92.55M | -70.61M | -82.71M |
| Income Before Tax | -151.39M | -103.97M | -79.75M | -56.07M | -67.42M |
| Income Tax Expenses | -1.40M | -1.31M | 1.38M | 7.36M | 6.25M |
| Earnings from Continuing Operations | -149.99 | -102.66 | -81.13 | -63.43 | -73.68 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -149.99M | -102.66M | -81.13M | -63.43M | -73.68M |
| EBIT | -155.56M | -114.05M | -92.55M | -70.61M | -82.71M |
| EBITDA | -150.65M | -107.79M | -84.82M | -60.97M | -72.61M |
| EPS Basic | -2.01 | -1.37 | -1.08 | -0.84 | -0.98 |
| Normalized Basic EPS | -1.27 | -0.87 | -0.66 | -0.47 | -0.56 |
| EPS Diluted | -2.02 | -1.37 | -1.08 | -0.85 | -0.98 |
| Normalized Diluted EPS | -1.27 | -0.87 | -0.66 | -0.47 | -0.56 |
| Average Basic Shares Outstanding | 298.77M | 301.11M | 301.61M | 300.94M | 301.30M |
| Average Diluted Shares Outstanding | 298.80M | 303.19M | 303.72M | 303.10M | 303.48M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |